Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 45

Results For "board"

803 News Found

Merck plans bioprocessing center in South Korea
News | May 05, 2023

Merck plans bioprocessing center in South Korea

The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.


Evonik starts construction of new U.S. facility for pharmaceutical lipids
News | April 29, 2023

Evonik starts construction of new U.S. facility for pharmaceutical lipids

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness


Biocon approves NCD issue
News | April 27, 2023

Biocon approves NCD issue

The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.


Tricog raises US$ 8.5 million in series B2 funding
News | April 25, 2023

Tricog raises US$ 8.5 million in series B2 funding

The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa


Boehringer Ingelheim inaugurates largest European development centre for biotechnology
News | April 25, 2023

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

New high-tech facility in Biberach offers attractive workplaces for more than 500 scientists


Cadila plans an injectable manufacturing facility in collaboration with Russia
News | April 22, 2023

Cadila plans an injectable manufacturing facility in collaboration with Russia

The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries


Digital Health: An opportunity to increase health equity
Digitisation | April 14, 2023

Digital Health: An opportunity to increase health equity

Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%


Apitoria Pharma  appoints Dr. Sanjay Chaturvedi as CEO
People | April 06, 2023

Apitoria Pharma appoints Dr. Sanjay Chaturvedi as CEO

Venkat Nageswar Chalasani has been appointed as an Independent Director of Apitoria Pharma with effect from April 4, 2023


Top management changes at IOL Chemicals and Pharmaceuticals
People | April 04, 2023

Top management changes at IOL Chemicals and Pharmaceuticals

Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company